Related Experiment Video
Updated: May 19, 2026
09:32
Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
Epilepsy meets cancer: when, why, and what to do about it?
Michael Weller1, Roger Stupp, Wolfgang Wick
1Department of Neurology, University Hospital Zurich, Zurich, Switzerland. michael.weller@usz.ch
The Lancet. Oncology
|September 1, 2012
Summary
Cancer patients face a significantly higher risk of epilepsy, with up to 80% developing seizures due to brain tumors or metastases. Managing this requires addressing cancer, preventing seizures with antiepileptic drugs, and minimizing treatment interactions.
Area of Science:
- Oncology
- Neurology
- Pharmacology
Background:
- Patients with cancer have a substantially increased lifetime risk of epileptic seizures.
- Approximately 20% of patients with systemic cancer develop brain metastases, increasing epilepsy risk.
- Primary brain tumors also carry a high lifetime epilepsy risk, ranging from 20-80%.
Purpose of the Study:
- To outline the multifaceted management of epilepsy in cancer patients.
- To highlight the challenges posed by drug-drug interactions in treating cancer-associated epilepsy.
- To emphasize the need for a multidisciplinary approach in managing epilepsy alongside cancer treatment.
Main Methods:
- Review of factors provoking seizures in cancer patients (brain metastases, primary tumors, treatments, metabolic issues, stroke, infection).
- Discussion of epilepsy management strategies including diagnosis, treatment of underlying pathology, and antiepileptic drug prophylaxis.
- Consideration of the impact of epilepsy and its treatment on cancer therapy, cognition, and quality of life.
Main Results:
- Epilepsy is a common complication in cancer patients, with varied risk factors.
- Effective management necessitates addressing the primary cancer, seizure control, and potential treatment interactions.
- A coordinated, multidisciplinary approach is crucial due to complex drug interactions.
Conclusions:
- Epilepsy management in cancer patients is complex, requiring integrated care.
- Careful consideration of drug-drug interactions between antiepileptic drugs and anticancer agents is paramount.
- Optimizing epilepsy treatment improves patient outcomes, tolerability, and quality of life.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:19Seizures ll: Types
Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...